Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055480
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.32K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+85$3.34+$283.9173,870Direct
Aug 3, 2021Common StockPPurchaseAcquired+85$3.17+$269.45173,955Direct
Aug 4, 2021Common StockPPurchaseAcquired+85$3.18+$270.3174,040Direct
Aug 5, 2021Common StockPPurchaseAcquired+85$3.11+$264.35174,125Direct
Aug 6, 2021Common StockPPurchaseAcquired+85$3.01+$255.85174,210Direct
Aug 9, 2021Common StockPPurchaseAcquired+85$2.93+$249.05174,295Direct
Aug 10, 2021Common StockPPurchaseAcquired+85$2.96+$251.6174,380Direct
Aug 11, 2021Common StockPPurchaseAcquired+85$2.98+$253.3174,465Direct
Aug 13, 2021Common StockPPurchaseAcquired+85$2.92+$248.2174,550Direct
Aug 16, 2021Common StockPPurchaseAcquired+85$2.92+$248.2174,635Direct
Aug 17, 2021Common StockPPurchaseAcquired+85$3.05+$259.25174,720Direct
Aug 18, 2021Common StockPPurchaseAcquired+85$2.97+$252.45174,805Direct
Aug 19, 2021Common StockPPurchaseAcquired+85$3.02+$256.7174,890Direct
Aug 20, 2021Common StockPPurchaseAcquired+85$2.96+$251.6174,975Direct
Aug 23, 2021Common StockPPurchaseAcquired+85$2.87+$243.95175,060Direct
Aug 24, 2021Common StockPPurchaseAcquired+85$2.89+$245.65175,145Direct
Aug 25, 2021Common StockPPurchaseAcquired+85$2.79+$237.15175,230Direct
Aug 26, 2021Common StockPPurchaseAcquired+85$2.82+$239.7175,315Direct
Aug 27, 2021Common StockPPurchaseAcquired+85$2.84+$241.4175,400Direct
Aug 30, 2021Common StockPPurchaseAcquired+85$2.88+$244.8175,485Direct
Aug 31, 2021Common StockPPurchaseAcquired+85$2.93+$249.05175,570Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)